Iovance Biotherapeutics, Inc. IOVA Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s net gains (losses) on investments?
- Iovance Biotherapeutics, Inc. (IOVA) reported net gains (losses) on investments of $85K in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s net gains (losses) on investments changed year-over-year?
- Iovance Biotherapeutics, Inc.'s net gains (losses) on investments decreased by 22.7% year-over-year, from $110K to $85K.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.